GA-AGCO
13.12.2022 14:31:37 CET | Business Wire | Press release
AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, received ten AE50 Awards from the American Society of Agricultural and Biological Engineers (ASABE) for 2023. Each year, an international panel of engineering experts recognizes the year’s 50 most innovative designs in engineering products or systems for the food and agriculture industries. AGCO’s ten AE50 awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221213005076/en/
AGCO Corp. won ten 2023 AE50 Awards from ASABE for innovative design in engineering products or systems for agriculture. AGCO’s awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting. Pictured above are the AE50 Award-winning Massey Ferguson WR Series Windrower and Fendt 700 Gen7 Vario tractor.(Photo: Business Wire)
“Innovation is core to our vision of being farmers’ most trusted partner for industry-leading, smart farming solutions and we’re honored to be recognized with ten AE50 Awards across our brand portfolio,” said Eric Hansotia, AGCO chairman, president, and chief executive officer. “Helping farmers maximize yield while reducing inputs and impact delivers real value to farmers and motivates our team to accelerate the pace of farmer-first innovation in every area of our business.”
The Fendt® 700 Gen7 Vario® is the brand’s most popular workhorse tractor. Redesigned to improve performance, reduce costs, and increase productivity, the tractor is one of the most versatile and operator-friendly tractors in its market segment with five models ranging from 203 to 283 engine hp, a standard VarioDrive™ CVT, FendtONE™ operators’ station, fuel-efficient AGCO Power™ 7.5L engine, and agronomic-boosting features such as the VarioGrip™ Central Tire Inflation System (CTIS).
Geo-Bird® from Fuse® is a free and intuitive web app that automatically optimizes waylines for multiple fields and implements, saving farmers time and money and supporting greater sustainability. Controlled Traffic Farming (CTF) waylines help farmers reduce time and cost requirements; turns, wheel traffic, and headland overlap; fuel usage and CO2 footprints; and yield-robbing soil compaction. Geo-Bird’s waylines are exportable to terminals of multiple brands for greater ease of use across disparate operations.
The Pit Level Monitor Model AP-6010 from AP (Automated Production®) uses electronic pressure transducers to efficiently measure effluent depth in manure pits below swine confinement facilities. This innovation provides swine facility operators with more accurate management information regarding manure pits, including early warnings of water leakage and remaining storage capacities.
The Massey Ferguson® LB2200 Series Large Square Baler merges the reliability of previous models with new cutting-edge technology advancements. A new pickup design improves baler feeding and parts reliability, while also reducing noise. New axle and tire offerings with a single bogie suspension improve ground clearance and rideability. Common Electric Architecture (CEA) provides greater information and control via ISOBUS terminal for Tractor Implement Management (TIM), bale length, bale eject, and bale chute fold.
The Massey Ferguson® WR Series Windrower provides up to 282 peak horsepower and an industry-exclusive closed-center hydraulic system for increased fuel efficiency and available header horsepower. This also eliminates the need for a secondary pump for auxiliary functions such as a triple windrow attachment (TWA). Technology updates improve field efficiency, reduce operator stress, and allow real-time tracking and data management. MF Guide ensures accurate auto-steering to minimize pass-to-pass overlap. Optional rear steer is available for road transport speeds up to 24.5 mph.
Recon SpraySense™ from Intelligent Ag™ is a retrofit sprayer product that measures pressure and flow at each nozzle to help ensure applications match targeted coverage and rates. GPS capability and a database of nozzles from major manufacturers infer accurate droplet size. Each nozzle’s performance is condensed as a single Spray Quality Score and provided to operators via an iPad application. Recon SpraySense is a turn-key solution and provides state-of-the-art technology on sprayers old and new.
ReClaim™ from Precision Planting® replaces nozzle bar endcaps in sprayers and provides a return path back to the tank for improved product agitation and circulation, faster boom priming, and improved boom cleanout. ReClaim also improves sprayer cleanout with compressed air that pushes product back to the tank where it is drained and properly disposed. These improvements reduce build-up in the boom, product waste on the ground, and crop damage from misapplication.
Precision Planting’s Radicle Agronomics™ is the world’s first, fully-automated soil laboratory. Its small footprint, self-calibration technology, and ability to run hundreds of unattended samples, replaces manual, error-prone processes and provides tremendous efficiency and improved accuracy to professional agronomists. Cloud-based software connects all steps of the field-to-lab process so agronomists can deliver superior nutrient management recommendations to their clients.
Precision Planting’s EM HD is a new liquid fertilizer controller and sensor that uses an electromagnetic flow sensor to provide row-by-row, high-speed liquid fertilizer rate control on row crop planters, side-dress implements, and strip-till implements. Immediate feedback from the flow sensor allows the system to make high-speed changes to the liquid valve control, which maintains a more accurate and consistent flow of fertilizer to the implement’s application point.
Precision Planting’s Blockage Expansion Module (BXM) is a monitoring component for non-singulated crop seeding implements that combines and connects multiple blockage sensors into a single connection point for 20|20 seed monitoring systems. By simplifying the implement’s electronic components and providing more user-friendly and actionable data, BXM improves the growers' ability to diagnose issues arising in the delivery of products from the commodity tanks to the application point.
For more information on these AE50 award-winning products, visit your nearest AGCO dealer, the links above, or AGCOcorp.com.
Online Version
An online version of this announcement with media downloads is available HERE.
Fendt, Fuse, Geo-Bird, Massey Ferguson, Precision Planting, and Vario are registered trademarks of AGCO. AGCO Power, FendtONE, Intelligent Ag, Radicle Agronomics, Recon SpraySense, VarioDrive, and VarioGrip are trademarks of AGCO.
About AGCO
AGCO (NYSE:AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers customer value through its differentiated brand portfolio including core brands like Challenger®, Fendt®, GSI®, Massey Ferguson®, Precision Planting® and Valtra®. Powered by Fuse® smart farming solutions, AGCO’s full line of equipment and services help farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $11.1 billion in 2021. For more information, visit www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005076/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
